Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion type Assertion NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_head.
- NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion description "[Selumetinib is an inhibitor of MEK1/MEK2, downstream of KRAS, with preclinical evidence of synergistic activity with docetaxel in KRAS-mutant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_provenance.
- NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion evidence source_evidence_literature NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_provenance.
- NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion SIO_000772 23200175 NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_provenance.
- NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion wasDerivedFrom befree-20140225 NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_provenance.
- NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_assertion wasGeneratedBy ECO_0000203 NP276946.RAS_Yn8GY1QgTqP6_aBkA_KJDHObvlyggV6GiOVTcQvVI130_provenance.